Entering text into the input field will update the search result below

Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 EPS of $0.73 beats by $0.04. Revenue of $370.1M beats...

Jul. 25, 2013 6:31 AM ETAlexion Pharmaceuticals, Inc. (ALXN) StockALXNBy: Gaurav Batavia, SA News Editor
Alexion Pharmaceuticals (NASDAQ:ALXN): Q2 EPS of $0.73 beats by $0.04. Revenue of $370.1M beats by $5.3M. (PR)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
ALXN--
Alexion Pharmaceuticals, Inc.